Arkolith/Insider Trading/BCAX/Form 4

Hyep Ivan

Chief Financial OfficerBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed Apr 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$212K
Net Open-Market Flow
-$212K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2026Option exercise(M)9K$3.79$35K155K
Apr 21, 2026Sell(S)9K$23.00$212K145K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 21, 2026Option exercise(M)9K—$040K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-026604) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML